Zoetis Inc (NYSE:ZTS)
| 158.69 Delayed Data As of Oct 28 |  -3.78 / -2.33%Today’s Change | 90.14 Today|||52-Week Range 168.96 | +19.90% Year-to-Date |
Latest ZTS News | Press Releases
| GRFS vs. ZTS: Which Stock Is the Better Value Option? Oct 28 / Zacks.com - Paid Partner Content | Top Analyst Reports for Netflix, Lockheed Martin & Zoetis Oct 23 / Zacks.com - Paid Partner Content |
| The Zacks Analyst Blog Highlights: Netflix, Lockheed, Zoetis, ITUB and Moderna Oct 26 / Zacks.com - Paid Partner Content | Is Zoetis (ZTS) Stock Outpacing Its Medical Peers This Year? Oct 16 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 162.47 |
| Today’s open | 159.76 |
| Day’s range | 158.16 - 161.51 |
| Volume | 2,160,674 |
| Average volume (3 months) | 1,525,254 |
| Market cap | $77.7B |
Data as of 4:00pm ET, 10/28/2020
Growth & Valuation
| Earnings growth (last year) | +6.13% |
| Earnings growth (this year) | +0.08% |
| Earnings growth (next 5 years) | +9.23% |
| Revenue growth (last year) | +7.47% |
| P/E ratio | 47.1 |
| Price/Sales | 10.19 |
| Price/Book | 28.71 |
Competitors
Data as of 5:17pm ET, 10/28/2020
Financials
| Next reporting date | November 5, 2020 |
| EPS forecast (this quarter) | $0.91 |
| Annual revenue (last year) | $6.3B |
| Annual profit (last year) | $1.5B |
| Net profit margin | 23.96% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Generic |
No executives to display |
Corporate headquarters Parsippany, New Jersey |
Forecasts
